Bank of New York Mellon’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.79M | Buy |
212,858
+2,123
| +1% | +$27.8K | ﹤0.01% | 2577 |
|
|
2025
Q1 | $4.64M | Sell |
210,735
-321
| -0.2% | -$7.06K | ﹤0.01% | 2253 |
|
|
2024
Q4 | $5.64M | Buy |
211,056
+284
| +0.1% | +$7.58K | ﹤0.01% | 2221 |
|
|
2024
Q3 | $5.63M | Sell |
210,772
-57,940
| -22% | -$1.55M | ﹤0.01% | 2237 |
|
|
2024
Q2 | $4.84M | Buy |
268,712
+56,447
| +27% | +$1.02M | ﹤0.01% | 2362 |
|
|
2024
Q1 | $3.87M | Buy |
212,265
+66,095
| +45% | +$1.21M | ﹤0.01% | 2438 |
|
|
2023
Q4 | $1.6M | Sell |
146,170
-114
| -0.1% | -$1.25K | ﹤0.01% | 2944 |
|
|
2023
Q3 | $838K | Sell |
146,284
-2,633
| -2% | -$15.1K | ﹤0.01% | 3258 |
|
|
2023
Q2 | $1.15M | Buy |
148,917
+25,037
| +20% | +$194K | ﹤0.01% | 3112 |
|
|
2023
Q1 | $826K | Sell |
123,880
-3,815
| -3% | -$25.4K | ﹤0.01% | 3216 |
|
|
2022
Q4 | $1.14M | Buy |
127,695
+31,834
| +33% | +$285K | ﹤0.01% | 3131 |
|
|
2022
Q3 | $943K | Sell |
95,861
-93,378
| -49% | -$919K | ﹤0.01% | 3231 |
|
|
2022
Q2 | $1.51M | Sell |
189,239
-23,648
| -11% | -$188K | ﹤0.01% | 2989 |
|
|
2022
Q1 | $2.07M | Sell |
212,887
-1,626
| -0.8% | -$15.8K | ﹤0.01% | 2915 |
|
|
2021
Q4 | $3.28M | Buy |
214,513
+179,099
| +506% | +$2.74M | ﹤0.01% | 2693 |
|
|
2021
Q3 | $588K | Buy |
35,414
+6,941
| +24% | +$115K | ﹤0.01% | 3713 |
|
|
2021
Q2 | $607K | Buy |
+28,473
| New | +$607K | ﹤0.01% | 3682 |
|